Aspect Partners »

Regeneron Pharmaceuticals shares owned by Aspect Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Aspect Partners from 13F filings

Historical chart of Aspect Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Aspect Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Aspect Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $20k 23 878.33

More positions owned by Aspect Partners

Spdr S&p 500 Etf Trust Etf (SPY)
Ishares U.s. Real Estate Etf Etf (IYR)
Ishares Msci Eafe Etf Etf (EFA)
Vanguard Total Stock Market Etf Etf (VTI)
Ishares Core International Aggregate Bond Etf Etf (IAGG)
Real Estate Select Sector Spdr Fund Etf (XLRE)
Invesco Optimum Yield Diversified Commodity Strategy No K-1 Etf Etf (PDBC)
Ishares 20 Year Treasury Bond Etf Etf (TLT)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Ishares Core Msci Eafe Etf Etf (IEFA)
Ishares Core S&p Small Cap Etf Etf (IJR)
Vanguard International Dividend Appreciation Etf Etf (VIGI)
Spdr Gold Shares Etf (GLD)
Alpha Architect 1-3 Month Box Etf Etf (BOXX)
Vaneck Gold Miners Etf Etf (GDX)

View all positions for Aspect Partners

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Dodge & Cox
Wellington Management Company
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
Amundi
Bank of New York Mellon
Citadel Advisors
Alliancebernstein
T. Rowe Price Associates
Ubs Global Asset Management Americas
Charles Schwab Investment Management
Dimensional Fund Advisors

View all funds holding Regeneron Pharmaceuticals